Debut
Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward.
Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward.
Tacta Systems is an advanced robotics company developing Dextrous Intelligence, the nervous system for robots. Its technology enables robots to perform delicate, variable, human-like tasks with flexibility, efficiency and autonomy.
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
Allay Therapeutics Read More »
Antheia is the next-generation pharmaceutical ingredient producer with a mission to end drug shortages. Using advanced biosynthesis and fermentation technology, Antheia’s biomanufacturing platform enables rapid, efficient, agile, and on-demand production of key starting materials (KSMs) and active pharmaceutical ingredients (APIs) that are critical to public health. This highly flexible approach supports the needs of a
Addepar is a global technology and data company that helps investment professionals provide the most informed, precise guidance for their clients. Hundreds of thousands of users have entrusted Addepar to empower smarter investment decisions and better advice over the last decade. With client presence in more than 50 countries, Addepar’s platform aggregates portfolio, market and
Elegen is bringing unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience developing novel and scalable approaches in molecular biology, chemistry and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realising the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies that enable targeted delivery of multi agents to tumor cells to maximize therapeutic benefit. Callio Therapeutics’ lead
Callio Therapeutics Read More »
Sunbird Bio is a biotechnology company developing proprietary blood-based diagnostic tests that provide unprecedented insights to enable earlier, more accurate diagnosis and treatment of neurological disorders and early-stage cancer. Sunbird’s innovative technologies uniquely detect the property and activity of proteins to empower researchers and clinicians with actionable information that is not available or accessible from
Borneo Data, Inc. was started by data and security practitioners with extensive experience in the challenges associated with protecting some of the largest data footprints in the world that includes Yahoo!, Facebook and Uber. Borneo has built a Security and Remediation Platform for securing critical data and sensitive information across complex and distributed cloud and
Founded by ex-Google executives, Arta Finance is a digital wealth platform for the savvy that enables more people to access the financial advantages of the ultra-wealthy. The platform provides access to private market investments from elite fund managers, intelligent public market portfolios, and sophisticated financial services such as tax and estate planning. Headquartered in the